| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.095 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.091 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |